Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qu Huangzhang
Kunming, Yunnan Province, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Yunnan Baiyao is a widely used traditional Chinese herbal medicine with hemostatic and wound-healing properties. It has been shown to reduce hospital-acquired pressure ulcers and improve wound healing by suppressing virulence gene expression and biofilm formation of Staphylococcus aureus. The product is available commercially in China for various bleeding disorders and wound care applications.
- Therapeutic areas
- DermatologyHematologyGastroenterology
- Modalities
- Herbal medicineSmall molecule
- Industry
- Biotech
02
Partnerships
Beiersdorf AG3M
Beyond the preview
Go deeper on Qu Huangzhang.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qu Huangzhang.